Explore the implications of GLP-1 drugs in managing India's obesity crisis as experts warn of potential misuse and health ...

NEW DELHI – India is witnessing a sharp rise in the demand for obesity and diabetes medications, with urban populations ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Mumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, ...

The demand for obesity drugs in India surges as Eli Lilly and Novo Nordisk vie for market share. Meanwhile, President Trump ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.